Dow takes green route to peptide production
Dow Chemical has taken a step forward in its plans to build up a strong franchise in plant-based pharmaceutical production with the signing of a contract to manufacture a new appetite suppressant.
Archives for February 20, 2004
Plague vaccine will be licensed within two years, says UK team
Scientists working for the UK government have taken a step forward in the development of an improved vaccine against plague, which wiped out a third of Europe's population in the 14th Century and has emerged more recently as a possible bioterrorist...
R&D budgets are on the up, predicts Qiagen CEO
Nucleic acid specialist Qiagen has reported a strong growth in sales and profits for the fourth quarter of 2003, providing another indication that the pharmaceutical and biotechnology industry's investment in R&D may be recovering.
First PDE-4 inhibitor moves closer to market
Germany's Altana has filed for European marketing approval of the first drug in new class - the phosphodiesterase-4 inhibitors - for asthma and chronic obstructive pulmonary disease.